Human serum hypoxanthine as a biomarker to predict recurrent major depressive disorder: a cross-sectional metabolomic study

Metabolic Brain Disease 2026

View at publisher

Authors: Yeeun Yun, Seungyeon Lee, Sora Mun, Hee‐Gyoo Kang, Jiyeong Lee

DOI: 10.1007/s11011-026-01810-2

Cited by: 0

References: 50

Fields of Study & Subjects

Treatment of Major Depression Metabolomics and Mass Spectrometry Studies Tryptophan and brain disorders

References 50